Bluejay Diagnostics, Inc. (BJDX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$6.05M | +22.6% |
| 2024 | -$7.82M | +5.9% |
| 2023 | -$8.31M | -7.4% |
| 2022 | -$7.74M | -77.3% |
| 2021 | -$4.37M | -758.4% |
| 2020 | -$508.7K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$6.05M | +22.6% |
| 2024 | -$7.82M | +5.9% |
| 2023 | -$8.31M | -7.4% |
| 2022 | -$7.74M | -77.3% |
| 2021 | -$4.37M | -758.4% |
| 2020 | -$508.7K | — |